
Short Interest in Plus Therapeutics, Inc. (NASDAQ:PSTV) Declines By 17.5%
Published on December 30, 2024
em>Institutional Investors Weigh In On Plus Therapeutics A hedge fund recently bought a new stake in Plus Therapeutics stock. AIGH Capital

em>Institutional Investors Weigh In On Plus Therapeutics A hedge fund recently bought a new stake in Plus Therapeutics stock. AIGH Capital